New study suggests: 📌Inflammation may not be the main driver of liver fibrosis in #MAFLD. 📌Hepatic lipopolysaccharide binding protein partially uncouples inflammation from fibrosis in MAFLD. 📌Targeting inflammation may not help reduce liver fibrosis. #medtwitter #livertwitter

What causes ACUTE LIVER FAILURE in 2024 ? 🔸Virus, no-viral causes, herbs.... 🔸What are the latest advances to treat this life-threatening condition ? This great review in The Lancet tells you all. t.ly/sEH_X Juan Pablo (JP) Arab, MD  Anand V Kulkarni TheLiverDoc

🚨 1 in 5 adults worldwide are expected to have #obesity by 2025. #MAFLD is found in over two thirds of subjects with obesity. #LiverTwitter #MedTwitter

Length of the GI tract 📏 - Are there any edits you would suggest?

Explore the current understanding and future perspectives on The contribution of Genetics and Epigenetics to MAFLD susceptibility. 👉link.springer.com/article/10.100…

Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. ja.ma/4fIm1hL

📢#MAFLD can coexist with chronic viral hepatitis. 🆕 Study‼️ ➡️ 63,273 subjects. ➡️The prevalence of MAFLD was 38.4%, compared with non-MAFLD patients: 📌 Diabetic MAFLD a/w~ 1.34-fold ⬆️ risk of HCC. 📌 Diabetic MAFLD a/w~ 1.43-fold ⬆️ risk of mortality.

Explore the current understanding and future perspectives on Metabolic Dysfunction Associated Fatty Liver Disease in Healthy Weight Individuals. 👉link.springer.com/article/10.100…

🔔🔔 New letter in HEPATOLOGY Journal #MAFLD vs #MASLD criteria debate: certainly not for children! ➡️ Authors “at least for children, the answer hands down is MAFLD!” AASLD 👉journals.lww.com/hep/fulltext/9… #Livertwitter #Medtwitter

FDA Approves Seladelpar for Primary Biliary Cholangitis The FDA has granted accelerated approval to seladelpar (Livdelzi) in combination with ursodeoxycholic acid for adults with primary biliary cholangitis. The drug, a peroxisome proliferator−activated receptor delta agonist,

⚠#MAFLD requires a multidisciplinary team. 🤝 We need to stimulate international collaborative work between hepatology specialists and related fields ✅ After all, organs communicate and so should we!😁 #LiverTwitter #MedTwitter

Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medications in conjunction with lifestyle modification according to their mechanism of action. ja.ma/3MgehWZ

📢 Check the special issue of Hepatology international guest-edited by Prof. Mohammed Eslam and Prof. Jacob George and written by giants in the field, it provides an updated review the state of the art research and clinical practice in #MAFLD. Cutting-edge insights await!

🚨High cholesterol is a major risk factor for #MAFLD and #heart disease! ✅ A healthy diet 🍽️ , regular exercise 🚴 🏃‍♀️ and medication 💊 can help reduce it. 👉maiden-apasl.com/patients-resou… #LiverTwitter #MedTwitter

Explore the current understanding and future perspectives on MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD. 👉link.springer.com/article/10.100…

🚨New study by Prof. Dr. Mohamed Alboraie MD. FRCP et al found that the words "fatty" and "steatotic" have the same translation in 17 non-Latin languages spoken by over 5 billion people worldwide.

A new letter by Prof. Yasser Fouad and Prof. Dr. Mohamed Alboraie MD. FRCP raises very logical questions on how F to S in the proposed new definition of MASLD turned premature to mature. Any thoughts?

Do you know that #MAFLD: ➡️ Doubles the risk of #diabetes. ➡️ Doubles the risk of CVD and CKD among patients with #diabetes. ➡️ Makes it harder to control blood glucose. ➡️ Resolution of #MAFLD decreases the risk of diabetes 🤝 MAFLD needs a multidisciplinary management.

❌ Obesity ❌ High blood pressure ❌ High cholesterol ❌ Smoking ❌ Diabetes ❌ Unhealthy diet ❌ Family history When we understand these ⬆️ we can better assess, control and monitor liver health. #MAIDEN #livertwitter

We are happy to announce an IBUS endorsed symposium in Egypt in collaboration with the Egyptian Society of Crohn's and Colitis (ESCCO) next week on September 12th. More information: escco-eg.org/workshop-regis… ESCCO_Society Frauke Petersen #IBUS #ESCCO #IUS #IBD